WuXi AppTec (WUXAY) Projected to Release Earnings on Monday

WuXi AppTec (OTCMKTS:WUXAY) will likely be releasing its resultson Monday, July 27th. Analysts expect WuXi AppTec to post earnings of $0.2321 per share and revenue of $1.9111 billion for the quarter.

WuXi AppTec (OTCMKTS:WUXAY) last released its quarterly earnings results on Monday, April 27th. The company reported $0.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The company had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.59 billion.

WuXi AppTec Stock Performance

OTCMKTS:WUXAY opened at $19.53 on Monday. The stock has a fifty day simple moving average of $17.46 and a 200 day simple moving average of $15.86. WuXi AppTec has a 1-year low of $11.52 and a 1-year high of $21.35.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a research note on Monday, April 13th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.